Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Publications
Sonpavde, Guru, Thomas E. Hutson, Matthew D. Galsky, and William R. Berry. “Problems with the randomized discontinuation design..” J Clin Oncol 24, no. 28 (October 1, 2006): 4669–70. https://doi.org/10.1200/JCO.2006.08.1026.
PMID
17008711
Anscher, Mitchell S., Jennifer Garst, Lawrence B. Marks, Nicole Larrier, Frank Dunphy, James E. Herndon, Robert Clough, et al. “Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury..” Int J Radiat Oncol Biol Phys 66, no. 2 (October 1, 2006): 477–82. https://doi.org/10.1016/j.ijrobp.2006.05.031.
PMID
16904841
Crawford, Jeffrey. “Disease management and patient-reported outcomes..” Support Cancer Ther 4, no. 1 (October 1, 2006). https://doi.org/10.3816/SCT.2006.n.025.
PMID
18632460
Rosoff, Philip M. “A central role for palliative care in an influenza pandemic..” J Palliat Med 9, no. 5 (October 2006): 1051–53. https://doi.org/10.1089/jpm.2006.9.1051.
PMID
17040141
Dinan, Michaela A., Kevin P. Weinfurt, Joëlle Y. Friedman, Jennifer S. Allsbrook, Julie Gottlieb, Kevin A. Schulman, Mark A. Hall, Jatinder K. Dhillon, and Jeremy Sugarman. “Comparison of conflict of interest policies and reported practices in academic medical centers in the United States..” Account Res 13, no. 4 (October 2006): 325–42. https://doi.org/10.1080/08989620601003414.
PMID
17849643
Brigidi, Bart D., Renee H. Raynor, and Henry S. Friedman. “Neurocognitive deficits according to hemisphere and diagnosis among patients with high-grade CNS tumors.” In Neuro Oncology, 8:476–77. DUKE UNIV PRESS, 2006.
Brigidi, Bart D., Renee H. Raynor, Melanie Bonner, Holly Schweitzer, Karen Carter, Bebe Guill, and Henry S. Friedman. “Development of the duke cancer cognitions inventory-brain tumor version (DCCI-BT).” In Neuro Oncology, 8:476–476. DUKE UNIV PRESS, 2006.
Aapro, M. S., D. A. Cameron, R. Pettengell, J. Bohlius, J. Crawford, M. Ellis, N. Kearney, et al. “EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours..” Eur J Cancer 42, no. 15 (October 2006): 2433–53. https://doi.org/10.1016/j.ejca.2006.05.002.
PMID
16750358
Li, Guojun, Xiaodong Zhai, Zhengdong Zhang, Robert M. Chamberlain, Margaret R. Spitz, and Qingyi Wei. “MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis..” Carcinogenesis 27, no. 10 (October 2006): 2028–33. https://doi.org/10.1093/carcin/bgl047.
PMID
16675470
Hjelmeland, Anita B., Katie Lattimore, Brian Fee, Sarah Wickman, Stephen T. Keir, Mark D. Hjelmeland, David Batt, et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” In Neuro Oncology, 8:412–412. DUKE UNIV PRESS, 2006.